文献速递慢病管理基层心理健康常见症状与未分化疾病

2022年基层医生应知的20项顶级研究

Top 20 Research Studies of 2022 for Primary Care Physicians.
PubMed 文献 · Am Fam Physician · 2023-01-01

本文总结2022年20项POEMs研究(排除COVID-19),涵盖他汀一级预防绝对获益小、维生素D不减少脆性骨折、SSRI为惊恐障碍首选、联合治疗优于单药治疗急性重度抑郁、PPI与胃癌风险增加相关、成人糖尿病前期部分可恢复正常血糖等,为基层临床决策提供证据。

要点

  • 他汀一级预防心血管病仅小幅降低死亡、心梗和卒中绝对风险。
  • 补充维生素D不减少脆性骨折风险,即使基线水平低或既往骨折。
  • SSRI为惊恐障碍首选药物,停药后复发风险增加(NNH=6)。

核心结论

  • 2022年20项POEMs研究为基层医生提供了关于他汀一级预防、维生素D、惊恐障碍、抑郁、失眠、哮喘、PPI、糖尿病前期、戒烟、大麻二酚相互作用及急性腰痛等临床问题的证据。

研究设计与样本

  • 本文总结2022年确定的20项POEMs(患者导向的重要证据)研究,排除COVID-19相关研究。

主要发现

  • 他汀一级预防心血管病在3至6年内仅小幅降低死亡(0.6%)、心肌梗死(0.7%)和卒中(0.3%)的绝对风险。
  • 补充维生素D不减少脆性骨折风险,即使基线维生素D水平低或既往有骨折。
  • SSRI是惊恐障碍首选药物治疗,停用抗抑郁药者比继续用药者更易复发(NNH=6)。
  • SSRI、SNRI或三环类抗抑郁药联合米氮平或曲唑酮,在急性重度抑郁一线治疗及单药治疗失败时比单药治疗更有效。
  • 成人失眠使用催眠药物在有效性和耐受性之间存在显著权衡。

关键数值与推荐

  • 他汀一级预防在3至6年内降低死亡的绝对风险为0.6%,心肌梗死为0.7%,卒中为0.3%。
  • 停用抗抑郁药后惊恐障碍复发的NNH=6。
  • 使用质子泵抑制剂者胃癌风险增加的10年NNH=1191。
  • 伐尼克兰初始处方疗程应为12周。

临床怎么用

  • 基层医生可参考这些POEMs证据,就他汀一级预防、维生素D补充、惊恐障碍和抑郁用药、失眠催眠药物选择、哮喘缓解治疗、PPI长期使用风险、糖尿病前期管理、戒烟治疗及急性下腰痛药物选择等与患者共同决策。

局限性

  • 本文为研究总结,排除COVID-19相关研究,部分证据来自观察性研究,证据强度和适用性需结合原文评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This article summarizes the top 20 research studies of 2022 identified as POEMs (patient-oriented evidence that matters), excluding COVID-19. Statins for primary prevention of cardiovascular disease produce only a small absolute reduction in a person's likelihood of dying (0.6%), having a myocardial infarction (0.7%), or having a stroke (0.3%) over three to six years. Supplemental vitamin D does not reduce the risk of a fragility fracture, even in people with low baseline vitamin D levels or a previous fracture. Selective serotonin reuptake inhibitors are preferred medical therapy for panic disorder, and patients who discontinue antidepressants are more likely to relapse (number needed to harm = 6) compared with those who continue. Combination therapy using a selective serotonin reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor, or tricyclic antidepressant with mirtazapine or trazodone is more effective than monotherapy for first-line treatment of acute severe depression and when monotherapy fails. Using hypnotic agents for insomnia in adults comes with a significant trade-off between effectiveness and tolerability. In patients with moderate to severe asthma, using a combination of albuterol and glucocorticoid inhalers as rescue therapy reduces exacerbations and need for systemic steroids. Observational research shows an increased risk of gastric cancer in patients taking proton pump inhibitors (number needed to harm = 1,191 over 10 years). The American College of Gastroenterology updated its guideline for gastroesophageal reflux disease, and a new guideline provides sound advice for the evaluation and management of irritable bowel syndrome. Adults older than 60 years with prediabetes are more likely to become normoglycemic than to develop diabetes mellitus or die. Treatment of prediabetes via intensive lifestyle intervention or metformin has no impact on long-term cardiovascular outcomes. Persons with painful diabetic peripheral neuropathy have similar degrees of improvement with monotherapy using amitriptyline, duloxetine, or pregabalin and greater improvement with combination therapy. When communicating with patients about disease risk, most patients prefer numbers over words because people overestimate word-based probabilities. In terms of drug therapy, the duration of an initial varenicline prescription should be 12 weeks. Many drugs can interact with cannabidiol. No important difference was found among ibuprofen, ketorolac, and diclofenac for treatment of acute nonradicular low back pain in adults.

来源:Am Fam Physician,查看原文。版权归原作者所有。

引用

  1. Grad R, Ebell MH. Top 20 Research Studies of 2022 for Primary Care Physicians. Am Fam Physician. 2023. PMID: 37054418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。